Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR): substudies of reservoirs and ultrasensitive drug resistance
Journal of Antimicrobial Chemotherapy · 2023
DOI: 10.1093/jac/dkad119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2023. Verfasst von Sidonie Lambert-Niclot und 18 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), 184 rue du Faubourg Saint-Antoine, 75571 Cedex 12, …. Hauptthemen laut MEDLINE: Anti-HIV Agents, HIV Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: ANRS, Emerging Infectious Diseases.
Abstract (Originalsprache)
Background
In a 4 days/week (4/7 days) maintenance strategy (ANRS-170 QUATUOR trial), the virological impact of an intermittent strategy was assessed by ultrasensitive virological analyses of reservoirs and resistance.
Methods
HIV-1 total DNA, ultra-sensitive plasma viral load (USpVL) and semen VL were measured in the first 121 participants. Sanger and ultra-deep sequencing (UDS) were performed on the HIV-1 genome (Illumina technology) according to the ANRS consensus. A generalized estimation equation with a Poisson distribution was used to compare changes in the proportion of residual viraemia, detectable semen HIV RNA and HIV DNA within and between the two groups over time.
Results
The proportion of participants with residual viraemia at Day 0 (D0) and Week 48 (W48) was 16.7% and 25.0% in the 4/7 days group and 22.4% and 29.7% in the 7/7 days group, respectively (+8.3% versus +7.3%, P = 0.971). The proportion of detectable DNA (>40 copies/106 cells) at D0 and W48 was 53.7% and 57.4% in the 4/7 days group and 56.1% and 51.8% in the 7/7 days group, respectively (+3.7% versus −4.3%, P = 0.358). Semen HIV RNA was detectable (≥100 copies/mL) in 2.2% of participants at D0 and 4.5% at W48 in the 4/7 days group versus 6.1% and 9.1% in the 7/7 days group, respectively (+2.3% versus +3.0%, P = 0.743). Emerging resistance at failure was more frequent in the 4/7 days group detected by Sanger sequencing: 3/6 participants versus 1/4 in the 7/7 days group, and similar with the UDS assay: 5/6 versus 4/4, respectively.
Conclusions
These findings support the potency of a 4/7 days maintenance strategy on virological suppression at the reservoirs and emergent resistance level, including minority variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), 184 rue du Faubourg Saint-Antoine, 75571 Cedex 12, Paris, France.
- AP-HP Hôpital Saint-Antoine, Laboratoire de Virologie, Paris, France.
- AP-HP Hôpital Pitié-Salpêtrière, Virology Department, Paris, France.
- Hôpitaux Universitaires Paris-Ile de France-Ouest, Hôpital Raymond Poincaré APHP, Université Versailles-Saint-Quentin, France, Infectious Diseases Department, Garches, France.
- Institut de Médecine et Epidémiologie Appliquée, Hôpital Bichat, Université Paris 7, Paris, France.
- Département de Pharmacologie-Toxicologie, Hôpital R Poincaré APHP, Inserm U-1173, Université Versailles-Saint-Quentin, Garches, France.
ORCID-Profile: Sidonie Lambert-Niclot, Basma Abdi, Jean-Claude Alvarez, Romain Palich, Dominique Costagliola
Förderung
- ANRS
- Emerging Infectious Diseases
Zitieren
APA
Lambert-Niclot, S., Abdi, B., Bellet, J., Fofana, D., De Truchis, P., Amat, K., Alvarez, J. C., Surgers, L., Allavena, C., Zaegell-Faucher, O., Morlat, P., Palich, R., Gibowski, S., Costagliola, D., Girard, P. M., Landman, R., Assoumou, L., Morand-Joubert, L., & ANRS 170 QUATUOR study group (2023). Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR): substudies of reservoirs and ultrasensitive drug resistance. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad119
Vancouver
Lambert-Niclot S, Abdi B, Bellet J, Fofana D, De Truchis P, Amat K, et al. Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR): substudies of reservoirs and ultrasensitive drug resistance. Journal of Antimicrobial Chemotherapy. 2023. doi:10.1093/jac/dkad119
BibTeX
@article{LambertNiclot2023,
author = {Lambert-Niclot, Sidonie and Abdi, Basma and Bellet, Jonathan and Fofana, Djeneba and De Truchis, Pierre and Amat, Karine and Alvarez, Jean-Claude and Surgers, Laure and Allavena, Clothilde and Zaegell-Faucher, Olivia and Morlat, Philippe and Palich, Romain and Gibowski, Séverine and Costagliola, Dominique and Girard, Pierre-Marie and Landman, Roland and Assoumou, Lambert and Morand-Joubert, Laurence and ANRS 170 QUATUOR study group, ANRS 170 QUATUOR study group},
title = {Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR): substudies of reservoirs and ultrasensitive drug resistance},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2023},
doi = {10.1093/jac/dkad119}
}
EUVIMED